Home • News • Major Advances on Influenza Vaccines
“CALIXAR and VirPath develop an innovative manufacturing process for high performance influenza vaccines“
Read related article : US to launch large scale universal flu shot testing in 2016
Starting from native material or recombinant systems, we succeed with all types of membrane proteins: GPCRs, Ions Channels, Transporters, Receptors and Viral Proteins.
© 2020 Calixar. All rights reserved.